Početna › Stargardtova bolest › Florida
Kliničke studije za Stargardtova bolest u državi Florida
8 studija za Stargardtova bolest traži sudionike na lokacijama u državi Florida.
Gradovi u državi Florida
Službeni tekst studije (engleski)
A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- University of Florida Health Science Center, Jacksonville
U tijeku regrutacijaFaza 1/2
Od 8 do 55 godina · Oba spola · Ažurirano 30. ruj 2026. · NCT07161544Study of ALK-001 on the Progression of Stargardt Disease
- Vitreo Retinal Associates, Gainesville
U tijeku regrutacijaFaza 3
Od 8 do 45 godina · Oba spola · Ažurirano 18. ruj 2026. · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
U tijeku regrutacijaOpažajna studija
Od 6 godina i više · Oba spola · Ažurirano 25. kol 2026. · NCT07425574Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
U tijeku regrutacija
Od 18 godina i više · Oba spola · Ažurirano 29. lip 2026. · NCT03011541Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Vitreo Retinal Associates, Gainesville
U tijeku regrutacijaOpažajna studija
Od 5 godina i više · Oba spola · Ažurirano 11. ožu 2026. · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
U tijeku regrutacijaFaza 1/2
Od 12 godina i više · Oba spola · Ažurirano 2. pro 2025. · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
U tijeku regrutacijaOpažajna studija
Od 12 do 65 godina · Oba spola · Ažurirano 19. ruj 2025. · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Bascom Palmer Eye Institute, Miami
U tijeku regrutacijaFaza 1/2
Od 12 do 65 godina · Oba spola · Ažurirano 29. tra 2025. · NCT06942572Iz ClinicalTrials.gov, podaci preuzeti 5. lis 2026.. Svaka studija ima svoje uvjete prihoda; tim studije odlučuje tko se može priključiti.